203 related articles for article (PubMed ID: 36773217)
1. Serum irisin levels and osteoporosis in patients with advanced chronic kidney disease and renal transplant recipients.
Demir C; Dursun AD; Sarıyıldız GT; Arslan Aİ
Int Urol Nephrol; 2023 Jul; 55(7):1821-1828. PubMed ID: 36773217
[TBL] [Abstract][Full Text] [Related]
2. Loss of bone mineral density in renal transplantation recipients.
Unal A; Kocyigit I; Sipahioglu MH; Tokgoz B; Kavuncuoglu F; Oymak O; Utas C
Transplant Proc; 2010 Nov; 42(9):3550-3. PubMed ID: 21094813
[TBL] [Abstract][Full Text] [Related]
3. Relationship between bone mineral density and biochemical markers of bone turnover in hemodialysis patients.
Sit D; Kadiroglu AK; Kayabasi H; Atay AE; Yilmaz Z; Yilmaz ME
Adv Ther; 2007; 24(5):987-95. PubMed ID: 18029324
[TBL] [Abstract][Full Text] [Related]
4. Bone Disease and Serum Fibroblast Growth Factor-23 Levels in Renal Transplant Recipients.
Coskun Y; Paydas S; Balal M; Soyupak S; Kara E
Transplant Proc; 2016; 48(6):2040-5. PubMed ID: 27569941
[TBL] [Abstract][Full Text] [Related]
5. Comparison of bone mineral density and biochemical factors in hemodialysis and peritoneal dialysis patients.
Yucel Kocak S; Ozdemir A
Clin Nephrol; 2022 Sep; 98(3):115-122. PubMed ID: 35880320
[TBL] [Abstract][Full Text] [Related]
6. Interrelationships between sarcopenia, bone turnover markers and low bone mineral density in patients on hemodialysis.
Wang Y; Ma W; Pu J; Chen F
Ren Fail; 2023 Dec; 45(1):2200846. PubMed ID: 37122165
[TBL] [Abstract][Full Text] [Related]
7. Treatment of hyperhomocysteinemia in hemodialysis patients and renal transplant recipients.
Bostom AG; Shemin D; Gohh RY; Beaulieu AJ; Bagley P; Massy ZA; Jacques PF; Dworkin L; Selhub J
Kidney Int Suppl; 2001 Feb; 78():S246-52. PubMed ID: 11169020
[TBL] [Abstract][Full Text] [Related]
8. Status of vitamin D and parameters of calcium homeostasis in renal transplant recipients in Nepal: a cross sectional study.
Timalsina S; Sigdel MR; Baniya S; Subedee S
BMC Nephrol; 2018 Oct; 19(1):290. PubMed ID: 30348109
[TBL] [Abstract][Full Text] [Related]
9. Correlation of serum levels of fibroblast growth factor 23 and Klotho protein levels with bone mineral density in maintenance hemodialysis patients.
Zheng S; Chen Y; Zheng Y; Zhou Z; Li Z
Eur J Med Res; 2018 Apr; 23(1):18. PubMed ID: 29665846
[TBL] [Abstract][Full Text] [Related]
10. Bone mineral density in Palestinian patients with end-stage renal disease and the related clinical and biochemical factors: Cross-sectional study.
Nazzal Z; Khader S; Zawyani H; Abdallah M; Sawalmeh O; Hamdan Z
PLoS One; 2020; 15(11):e0241201. PubMed ID: 33180791
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of biochemical markers and bone mineral density in patients with chronic kidney disease stage 5D at the start of hemodialysis treatment.
Valkovsky I; Olsanska R; Tvrdik J; Martinek A; Svagera Z; Pernicova M; Dedochova J; Cermakova Z
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Mar; 159(1):93-9. PubMed ID: 24322342
[TBL] [Abstract][Full Text] [Related]
12. Bone mineral densitometry in patients on hemodialysis: difference between genders and what to measure.
Orlic L; Crncevic Z; Pavlovic D; Zaputovic L
Ren Fail; 2010 Jan; 32(3):300-8. PubMed ID: 20370444
[TBL] [Abstract][Full Text] [Related]
13. Chronic kidney disease is associated with low BMD at the hip but not at the spine.
Bezerra de Carvalho KS; Vasco RFV; Custodio MR; Jorgetti V; Moysés RMA; Elias RM
Osteoporos Int; 2019 May; 30(5):1015-1023. PubMed ID: 30693381
[TBL] [Abstract][Full Text] [Related]
14. Chronic hemodialysis is associated with lower trabecular bone score, independent of bone mineral density: a case-control study.
Dusceac R; Niculescu DA; Dobre R; Dragne MC; Tacu C; Peride I; David C; Checherita I; Poiana C
Arch Osteoporos; 2018 Nov; 13(1):125. PubMed ID: 30426286
[TBL] [Abstract][Full Text] [Related]
15. Differences in cardiac structure assessed by echocardiography between renal transplant recipients and chronic kidney disease patients.
Dounousi E; Mitsis M; Naka KK; Pappas C; Lakkas L; Harisis C; Pappas K; Koutlas V; Tzalavra I; Spanos G; Michalis LK; Siamopoulos KC
Transplant Proc; 2014 Nov; 46(9):3194-8. PubMed ID: 25420857
[TBL] [Abstract][Full Text] [Related]
16. [A Cross-sectional Study of Osteoporosis and Cardiovascular Calcification in Patients with Chronic Kidney Disease at Different CKD Stages].
Cai ZY; Hu XF; Chen LQ; Li ZR; Du XG
Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 Mar; 52(2):334-339. PubMed ID: 33829711
[TBL] [Abstract][Full Text] [Related]
17. The correlation between sclerostin and bone mineral density in renal transplant recipients.
Coban M; Okten S
Nefrologia (Engl Ed); 2020; 40(5):506-513. PubMed ID: 32896441
[TBL] [Abstract][Full Text] [Related]
18. Serum irisin level is higher in peritoneal dialysis than in hemodialysis.
Song XY; Zhou SJ; Zhang JL; Zhou T; Wang SY; Pang Q; Pan YJ; Zhang AH
Int Urol Nephrol; 2023 May; 55(5):1329-1334. PubMed ID: 36527594
[TBL] [Abstract][Full Text] [Related]
19. Plasma Urotensin II levels in children and adolescents with chronic kidney disease: a single-centre study.
Garoufi A; Drapanioti S; Marmarinos A; Askiti V; Mitsioni AJ; Mila M; Grigoriadou G; Georgakopoulos D; Stefanidis CJ; Gourgiotis D
BMC Nephrol; 2017 Mar; 18(1):113. PubMed ID: 28359257
[TBL] [Abstract][Full Text] [Related]
20. Serum levels of the adipomyokine irisin in patients with chronic kidney disease.
Rodríguez-Carmona A; Pérez Fontán M; Sangiao Alvarellos S; García Falcón T; Pena Bello ML; López Muñiz A; Cordido F
Nefrologia; 2016; 36(5):496-502. PubMed ID: 27590717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
